SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-019486
Filing Date
2019-04-03
Accepted
2019-04-03 06:02:36
Documents
4
Period of Report
2019-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-7659_18k.htm 8-K 24621
2 EX-10.1 a19-7659_1ex10d1.htm EX-10.1 111767
3 GRAPHIC g76591ks03i001.jpg GRAPHIC 26122
4 GRAPHIC g76591ks03i002.jpg GRAPHIC 36780
  Complete submission text file 0001104659-19-019486.txt   224653
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 19727421
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences